Market Overview

Benzinga's Top Downgrades

Related TEVA
Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue
Teva Reports Results of Strategic Review, Sees 14 Pipeline Projects Possible for Divestment, Discontinuation
Sofinnova Ventures Closes $500M Fund (Fox Business)
Related QEP
IBM's Report Weighs On The Dow, Apple Helps Boost The Nasdaq, S&P 500 Extends Winning Streak
Benzinga's Volume Movers
Energy Stocks Move Higher as Oil Spikes (Fox Business)

Analysts at JP Morgan downgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “overweight” to “neutral.” The target price for Teva has been lowered from $45 to $43. Teva's shares closed at $38.88 yesterday.

Deutsche Bank downgraded QEP Resources (NYSE: QEP) from “buy” to “hold.” The target price for QEP Resources has been lowered from $37 to $34. QEP Resources' shares closed at $28.78 yesterday.

Baird downgraded Brady (NYSE: BRC) from “outperform” to “neutral.” The target price for Brady has been lowered from $41 to $33. Brady's shares closed at $30.52 yesterday.

Analysts at DA Davidson downgraded Under Armour (NYSE: UA) from “buy” to “neutral.” Under Armour's shares closed at $80.59 yesterday.

Latest Ratings for TEVA

DateFirmActionFromTo
Oct 2014Standpoint ResearchUpgradesHoldBuy
Oct 2014Standpoint ResearchDowngradesBuyHold
Aug 2014UBSMaintainsNeutral

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BRC + QEP)

Around the Web, We're Loving...

Get Benzinga's Newsletters